Ortho-(1-phenylvinyl)benzyl glycosides: Ether-type glycosyl donors for the efficient synthesis of both O-glycosides and nucleosides

被引:15
作者
Li, Penghua [1 ,2 ]
He, Haiqing [1 ]
Xu, Lili [1 ]
Huang, Yingying [1 ]
Chen, Zixi [1 ]
Zhang, Yunqin [1 ]
Yang, Rui [1 ]
Xiao, Guozhi [1 ]
机构
[1] Chinese Acad Sci, Univ Chinese Acad Sci, Kunming Inst Bot, State Key Lab Phytochem & Plant Resources West Chi, Kunming 650201, Peoples R China
[2] Yunnan Univ, Sch Chem Sci & Technol, Kunming 650091, Peoples R China
来源
GREEN SYNTHESIS AND CATALYSIS | 2020年 / 1卷 / 02期
关键词
Glycosylation; O-Glycosides; Nucleosides; ortho-(1-Phenylvinyl)benzyl; Glycosides; GENERAL-SYNTHESIS; N-GLYCOSYLATION; CAPECITABINE; FLUORINE; PURINE; CANCER; ALKYNYLBENZOATES; AMIPURIMYCIN; PYRIMIDINES; DISCOVERY;
D O I
10.1016/j.gresc.2020.10.003
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Both O-glycosides and nucleosides are essential biomolecules with important roles in a variety of biological processes. Chemical synthesis of both O-glycosides and nucleosides is a scalable and reliable method to develop new therapeutic agents and decipher their functions. However, the efficient synthesis of both O-glycosides and nucleosides remains one of long-standing challenges in chemical synthesis. In particular, ether-type glycosyl donors are rarely developed to achieve the efficient synthesis of both O-glycosides and nucleosides due to the stronger conditions required for breaking of the glycosidic C-O bond. Here we report that ortho-(1-phenylvinyl) benzyl glycosides are new ether-type donors for efficient synthesis of both O-glycosides and nucleosides under mild reaction conditions. This glycosylation method enables glycosylation with both alcoholic acceptors and nucleobases with a variety of reactive functionalities. Furthermore, the latent-active synthesis of glycans and the efficient synthesis of nucleosides antibiotics have also been successfully demonstrated in the current glycosylation protocol, thereby representing an important step toward streamlining the chemical synthesis of both O-glycosides and nucleosides.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 75 条
[1]   The Experimental Evidence in Support of Glycosylation Mechanisms at the SN1-SN2 Interface [J].
Adero, Philip Ouma ;
Amarasekara, Harsha ;
Wen, Peng ;
Bohe, Luis ;
Crich, David .
CHEMICAL REVIEWS, 2018, 118 (17) :8242-8284
[2]   CISPLATIN, DOXORUBICIN, CYCLOPHOSPHAMIDE, AND ETOPOSIDE COMBINATION CHEMOTHERAPY FOR SMALL-CELL LUNG-CANCER [J].
AISNER, J ;
WHITACRE, MY ;
BUDMAN, DR ;
PROPERT, K ;
STRAUSS, G ;
VANECHO, DA ;
PERRY, M .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1992, 29 (06) :435-438
[3]   Methods for 2-Deoxyglycoside Synthesis [J].
Bennett, Clay S. ;
Galan, M. Carmen .
CHEMICAL REVIEWS, 2018, 118 (17) :7931-7985
[4]   Chemical glycobiology [J].
Bertozzi, CR ;
Kiessling, LL .
SCIENCE, 2001, 291 (5512) :2357-2364
[5]  
Boltje TJ, 2009, NAT CHEM, V1, P611, DOI [10.1038/NCHEM.399, 10.1038/nchem.399]
[6]   EFFICIENT SYNTHESIS OF 2'-O-ALKYL RIBONUCLEOSIDES USING TRICHLOROACETIMIDATE D-RIBOFURANOSIDES AS RIBOSYL DONORS [J].
CHANTELOUP, L ;
THUONG, NT .
TETRAHEDRON LETTERS, 1994, 35 (06) :877-880
[7]   PENTENYL RIBOSIDES - NEW REAGENTS FOR PURINE NUCLEOSIDE SYNTHESIS [J].
CHAPEAU, MC ;
MARNETT, LJ .
JOURNAL OF ORGANIC CHEMISTRY, 1993, 58 (25) :7258-7262
[8]   STEREOSPECIFIC VORBRUGGEN-LIKE REACTIONS OF 1,2-ANHYDRO SUGARS - AN ALTERNATIVE ROUTE TO THE SYNTHESIS OF NUCLEOSIDES [J].
CHOW, K ;
DANISHEFSKY, S .
JOURNAL OF ORGANIC CHEMISTRY, 1990, 55 (13) :4211-4214
[9]   Recent highlights in modified oligonucleotide chemistry [J].
Cobb, Alexander J. A. .
ORGANIC & BIOMOLECULAR CHEMISTRY, 2007, 5 (20) :3260-3275
[10]   Why are the hydroxy groups of partially protected N-acetylglucosamine derivatives such poor glycosyl accepters, and what can be done about it?: A comparative study of the reactivity of N-acetyl-, N-phthalimido-, and 2-azido-2-deoxy-glucosamine derivatives in glycosylation.: 2-picolinyl ethers as reactivity-enhancing replacements for benzyl ethers [J].
Crich, D ;
Dudkin, V .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2001, 123 (28) :6819-6825